HomeComparePCCT vs ABBV

PCCT vs ABBV: Dividend Comparison 2026

PCCT yields 31.95% · ABBV yields 3.12%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PCCT wins by $43.3K in total portfolio value
10 years
PCCT
PCCT
● Live price
31.95%
Share price
$6.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$148.0K
Annual income
$20,681.98
Full PCCT calculator →
ABBV
AbbVie Inc.
● Live price
3.12%
Share price
$213.22
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$104.7K
Annual income
$25,725.73
Full ABBV calculator →

Portfolio growth — PCCT vs ABBV

📍 PCCT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCCTABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCCT + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCCT pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCCT
Annual income on $10K today (after 15% tax)
$2,715.65/yr
After 10yr DRIP, annual income (after tax)
$17,579.68/yr
ABBV
Annual income on $10K today (after 15% tax)
$265.10/yr
After 10yr DRIP, annual income (after tax)
$21,866.87/yr
At 15% tax rate, ABBV beats the other by $4,287.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCCT + ABBV for your $10,000?

PCCT: 50%ABBV: 50%
100% ABBV50/50100% PCCT
Portfolio after 10yr
$126.4K
Annual income
$23,203.85/yr
Blended yield
18.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

PCCT
No analyst data
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+20.1% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCCT buys
0
ABBV buys
0
No recent congressional trades found for PCCT or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCCTABBV
Forward yield31.95%3.12%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.6%
Portfolio after 10y$148.0K$104.7K
Annual income after 10y$20,681.98$25,725.73
Total dividends collected$103.4K$63.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PCCT vs ABBV ($10,000, DRIP)

YearPCCT PortfolioPCCT Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$13,895$3,194.89$11,559$438.51+$2.3KPCCT
2$19,016$4,148.84$13,494$640.86+$5.5KPCCT
3$25,654$5,306.59$15,951$945.97+$9.7KPCCT
4$34,140$6,690.54$19,152$1,413.89+$15.0KPCCT
5$44,852$8,321.27$23,443$2,146.38+$21.4KPCCT
6$58,208$10,216.78$29,391$3,321.96+$28.8KPCCT
7$74,674$12,391.82$37,948$5,265.87+$36.7KPCCT
8$94,759$14,857.32$50,795$8,596.74+$44.0KPCCT
9$119,012$17,619.97$71,034$14,549.41+$48.0KPCCT
10$148,025$20,681.98$104,715$25,725.73+$43.3KPCCT

PCCT vs ABBV: Complete Analysis 2026

PCCTStock

Perception Capital Corp. II does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a technology-enabled company with a proven business model operating within various sectors related to industrial technology. The company was incorporated in 2021 and is based in Wayzata, Minnesota.

Full PCCT Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this PCCT vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCCT vs SCHDPCCT vs JEPIPCCT vs OPCCT vs KOPCCT vs MAINPCCT vs JNJPCCT vs MRKPCCT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.